Peripheral neuropathy can be caused by compression of a nerve (like carpal tunnel syndrome), physical injury to a nerve such ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the medicine sparsentan (Filspari) to treat ...

NORTH CHICAGO, IL, USA I 18, 2024 I AbbVie (NYSE: ABBV) today announced the European Commission (EC) granted marketing authorization for ELAHERE® ...

University of California, San Diego-led research suggests that long-term variability in blood pressure is associated with ...

Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to ...

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, ...

For columnist Leigh Anne Nelson, multiple sclerosis has resulted in numbness, tingling, and a lack of coordination in her ...

Intellia Therapeutics ( (NTLA) ) just unveiled an announcement.Don't Miss our Black Friday Offers:Discover the latest stocks recommended by top ...

Laser therapies may help with pain after a root canal, but a review of published studies shows their effectiveness can vary significantly. Further research is needed to identify the optimal approach.

Intellia Therapeutics, Inc. (NASDAQ:NTLA) has released positive new clinical data from the ongoing phase 1 trial of Nexiguran Ziclumeran (Nex-Z), also known as NTLA-2001, in patients with ...

A preliminary study of an artificial intelligence-powered program found that it could detect if a person had high blood ...

Clene (NASDAQ:CLNN – Free Report) had its price target cut by Canaccord Genuity Group from $86.00 to $83.00 in a research report released on Thursday morning,Benzinga reports. They currently have a ...